Lack of diversity occurs at all levels of the pharmaceutical ecosystem, from the makeup of C-suite and research staffs to participation in clinical trials. It even extends to preclinical research.

As global biodiversity continues to decline, one of the more subtle yet serious threats facing endangered species is genomic erosion, the gradual loss of genetic diversity within a population ...

Curriculum that centers on diversity, equity, and inclusion is also a powerful support for ESL teachers, who are often ...

The landscape of human health is undergoing profound transformation, shaped by demographic shifts, environmental challenges, and rapid technological ...

Once the groups split (remember, just a short 1.5 million years ago), the study found that Population A experienced a “bottleneck,” or a drastic drop in population size and genetic diversity.

There is a significant and concerning decline in the genetic diversity of British nightjar populations over the past two ...

Of the global population, only 12% of individuals are actually “WEIRD”; however, 95% of psychological and behavioral research participants are from this group.

Universities across the country are scrambling to comply with President Donald Trump’s anti-diversity push in an effort to hold on to hundreds of millions of dollars in federal grants that fund ...

Population genetics explores the distribution and change in frequency of alleles within and between populations, while genetic diversity underpins the capacity of species to adapt to environmental ...

In recent years, women have made up about 40 percent of clinical trial participants among studies for common conditions like cancer and heart disease, despite being half the population who has ...

Although her recent study acknowledges potential differences between White and non-White patients with psoriatic arthritis (PsA), Rebecca Haberman, MD, NYU Langone Health, emphasizes the need for ...